HL7/NCPDP Informative Document: Standardized Medication Profile, Release 1

DESCRIPTION

This white paper identifies and defines the components of an interoperable medication profile for clinicians, patients and caregivers to use for the exchange of essential medication information during transitions of care to and from post-acute care settings. This paper also proposes recommendations to the Centers for Medicare & Medicaid Services (CMS) based on what NCPDP and HL7 have identified.

ALTERNATIVE NAMES

HL7/NCPDP Informative Document: Standardized Medication Profile, Release 1 may also go by the following names or acronyms:

BENEFITS

• Identifies and defines the components of an interoperable medication profile
• Harmonizes, and identifies gaps between, NCPDP and HL7 standards
• Supports patient medication safety and continuity of care during transitions of care.

DEVELOPMENT BACKGROUND

NCPDP WG14/WG10 Standardized Medication Profile Task Group completed an analysis of data fields and transactions available in the current NCPDP SCRIPT and Specialized standards (as defined by the IMPACT Act) and documented existing data fields that meet patient and medication profile attributes and specific gaps.

In September 2019, an HL7 Standardized Medication Profile Project Scope Statement was initiated.

Content was primarily developed in NCPDP with participation of members of HL7 Pharmacy WG.

RELATED DOCUMENTS

HL7/NCPDP Informative Document: Standardized Medication Profile, Release 1

(Download) (418 KB)

TOPIC

• Pharmacy

BALLOT TYPE

• Informative

STATUS DATE

2021-09-08

RESPONSIBLE WORK GROUP

PRODUCT TYPE

• White Paper

STAKEHOLDERS

• EHR, PHR Vendors
• Health Care IT Vendors
• Healthcare Institutions
• Regulatory Agency
• Standards Development Organizations (SDOs)

FAMILY

• Cross-paradigm

CURRENT STATE

• Active

REALM

• US Realm